Cite This Page

Jump to: navigation, search

Bibliographic details for Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1

Citation styles for Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1

APA style

Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1. (2024, January 25). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 06:51, May 7, 2024 from https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216.

MLA style

"Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 25 Jan 2024, 15:24 UTC. 7 May 2024, 06:51 <https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216>.

MHRA style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 25 January 2024, 15:24 UTC, <https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216> [accessed 7 May 2024]

Chicago style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216 (accessed May 7, 2024).

CBE/CSE style

OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1 [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 25, 15:24 UTC [cited 2024 May 7]. Available from: https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216.

Bluebook style

Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1, https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216 (last visited May 7, 2024).

BibTeX entry

 @misc{ wiki:xxx,
   author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
   title = "Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1 --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
   year = "2024",
   url = "https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216",
   note = "[Online; accessed 7-May-2024]"
 }

When using the LaTeX package url (\usepackage{url} somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred: 

 @misc{ wiki:xxx,
   author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
   title = "Realworld success outcomes of seriously pretreated sufferers along with refractory HR HER2metastatic cancer of the breast obtaining singleagent chemotherapya evaluation using MONARCH 1 --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
   year = "2024",
   url = "\url{https://news.npo.digital/index.php?title=Realworld_success_outcomes_of_seriously_pretreated_sufferers_along_with_refractory_HR_HER2metastatic_cancer_of_the_breast_obtaining_singleagent_chemotherapya_evaluation_using_MONARCH_1&oldid=616216}",
   note = "[Online; accessed 7-May-2024]"
 }


Retrieved from "https://news.npo.digital/index.php?title=Special:CiteThisPage"